Medical device company CooperCompanies (NASDAQ:COO) reported Q1 CY2026 results exceeding the market’s revenue expectations, with sales up 7.9% year on year to $1.08 billion. The company expects the full year’s revenue to be around $4.30 billion, close to analysts’ estimates. Its non-GAAP profit of $1.21 per share was 10.5% above analysts’ consensus estimates.
...